Results 111 to 120 of about 11,268 (139)

AfroColombian ethnicity, a paradoxical protective factor against Dengue. [PDF]

Colomb Med (Cali), 2016
Rojas Palacios JH, Alzate A, Martínez Romero HJ, Concha-Eastman AI.   +3 more
europepmc   +1 more source

[Use of ribavirin in viruses other than hepatitis C. A review of the evidence]. [PDF]

Enferm Infecc Microbiol Clin, 2019
Ramírez-Olivencia G, Estébanez M, Membrillo FJ, Ybarra MDC.   +3 more
europepmc   +1 more source

Educational technologies to promote the sexual and reproductive health of women with HIV: an integrative review. [PDF]

Rev Bras Enferm
Rocha KAA, Rocha DM, Antonini M, Elias HC, Gir E, Reis RK.   +5 more
europepmc   +1 more source

Content, educational value and quality analysis of videos about neurorehabilitation in people with multiple sclerosis on YouTube®. [PDF]

Rev Neurol
Cano-de-la-Cuerda R, Marcos-Antón S, Blázquez-Fernández A, Fernández-Cañas M, Sánchez-Herrera Baeza P, Fernández-González P, Collado-Vázquez S, Jiménez-Antona C, Laguarta-Val S.   +8 more
europepmc   +1 more source

[Comorbidities in multiple sclerosis and their influence on the choice of treatment]. [PDF]

Rev Neurol
Barboza A, Sinay V, Alonso R, Carnero-Contentti E, Hryb J, Silva B, Tavolini D, Ysrraelit MC, Correale J.   +8 more
europepmc   +1 more source

Defining characteristics predicting mental health disorders among undergraduate students in the post-COVID-19 era: a multicenter cross-sectional study. [PDF]

Rev Lat Am Enfermagem
Moura CC, Toledo LV, Boscarol GT, Chaves RL, Nogueira DA, Marinho CADC, Alves BO, Lourenço BG, Chaves ÉCL, Chianca TCM.   +9 more
europepmc   +1 more source

[Expansion of family medicine in Latin America: challenges and lines of actionExpansão da medicina familiar na América Latina: desafios e linhas de ação].

Rev Panam Salud Publica, 2018
Calbano AG, Anderson MIP, Rodríguez ART, Godoy AC, Quintana HMB, Martins I, García JCP, Muñoz K, Orellana P, Carrasco RV, Cardozo V, Romero XA.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

Lancet, The, 2021
Anthony Guy Marson, Girvan Burnside, David Smith   +2 more
exaly